Position in GRAL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,837,802
+$1,799,669 QoQ
Shares Held
114,806
-1.7% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,851,050,635 across 36 Diagnostics & Research names. GRAL ranks #22 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
8,503,527 | $4,263,328,287 | |
| 2 | NTRA |
Natera, Inc.
|
12,865,346 | $3,492,298,164 | |
| 3 | DHR |
Danaher Corp /De/
|
12,185,400 | $2,321,074,982 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
6,139,775 | $1,186,327,314 | |
| 5 | WAT |
Waters Corp /De/
|
2,158,391 | $809,482,952 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,520,438 | $746,156,824 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
755,791 | $397,878,607 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,268,384 | $355,147,520 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,837,802 | 114,806 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $6,038,133 | 116,837 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $12,109,100 | 141,478 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $12,187,873 | 206,120 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $4,090,150 | 79,544 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $941,632 | 36,869 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $310,659 | 17,404 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $908,087 | 65,995 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $1,592,479 | 103,610 | Shares | Other | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||